GLP-1 Medications
Semaglutide, Tirzepatide, and related weight loss medications
Quick Answer
GLP-1 receptor agonists (semaglutide/Wegovy, tirzepatide/Zepbound) are the most effective weight loss medications ever developed, producing 15-25% body weight loss in clinical trials. They work by reducing appetite and slowing gastric emptying. They require a prescription, cost $500-1,500/month, and have common GI side effects. They're most appropriate for obesity (BMI >30) or overweight with metabolic complications.
High Evidence
Strong clinical trial data in humans
Safety: GLP-1 medications require a prescription and medical supervision. Generally well-tolerated but with common GI side effects.
What Is This?
GLP-1 (glucagon-like peptide-1) receptor agonists are a class of medications originally developed for type 2 diabetes that have proven remarkably effective for weight loss.
Current options include:
- Semaglutide (Ozempic for diabetes, Wegovy for weight loss) - weekly injection
- Tirzepatide (Mounjaro for diabetes, Zepbound for weight loss) - weekly injection, dual GLP-1/GIP agonist
- Liraglutide (Saxenda) - daily injection, less effective than newer options
- Oral semaglutide (Rybelsus) - daily pill, primarily for diabetes
How It Works
GLP-1 medications work through multiple mechanisms:
Appetite Suppression: They act on brain regions controlling hunger and satiety, reducing the drive to eat. Many people describe a "food noise" quieting, constant thoughts about food diminish.
Slowed Gastric Emptying: Food stays in your stomach longer, extending the feeling of fullness after meals.
Improved Insulin Response: They enhance insulin secretion when blood sugar is elevated, reducing post-meal glucose spikes.
Food Preference Changes: Many users report reduced interest in hyper-palatable foods (sweets, fried foods) and find it easier to choose healthier options.
Clinical Results:
- Semaglutide (Wegovy): Average 15-17% weight loss in trials
- Tirzepatide (Zepbound): Average 20-25% weight loss in trials
- These exceed any previous medication or lifestyle intervention in clinical trials
How to Start
Evaluate if you're a candidate
GLP-1s are FDA-approved for obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related condition (diabetes, high blood pressure, high cholesterol). Talk to your doctor about whether you're a candidate.
Tips:
- •Calculate your BMI: weight (kg) / height (m)²
- •Consider non-medication approaches first if you haven't tried them
- •Have realistic expectations: these are tools, not magic pills
Get a prescription
Consult with your primary care doctor, endocrinologist, or obesity medicine specialist. Telehealth services (Calibrate, Found, Ro) also prescribe these medications but costs vary. Your doctor will check for contraindications.
Tips:
- •Insurance coverage varies widely, check your plan
- •Manufacturer savings programs may reduce costs
- •Some telehealth services include coaching and support
Start at the lowest dose
All GLP-1s start at low doses that gradually increase over weeks to months. This minimizes side effects. Semaglutide starts at 0.25mg and increases to 2.4mg; tirzepatide starts at 2.5mg and increases to 15mg.
Tips:
- •Don't skip the titration, side effects are worse if you start high
- •Dose increases typically happen every 4 weeks
- •Your doctor may slow titration if side effects are significant
Maintain lifestyle habits
GLP-1s work best when combined with improved diet and exercise. Focus on protein intake (muscle loss is a concern), resistance training, and sustainable eating habits. The medication makes these easier, not unnecessary.
Tips:
- •Prioritize protein (0.8-1g per pound of goal body weight) to minimize muscle loss
- •Include resistance training 2-3x/week
- •Establish habits that will sustain weight maintenance if you stop the medication
What to Expect
Initial adjustment
At starting doses, effects are mild. You may notice slightly reduced appetite. GI side effects (nausea, constipation) are possible but usually manageable. Weight loss is minimal initially.
Increasing effects
As doses increase, appetite suppression becomes more pronounced. Most people experience significant reduction in "food noise" and find it easier to eat less. Weight loss accelerates (1-2 lbs/week typical).
Peak weight loss
Maximum weight loss typically occurs between months 4-12 at maintenance doses. Average loss of 15-25% of body weight in trials. Energy levels may improve as metabolic health improves.
Maintenance phase
Weight typically stabilizes. Continued use maintains weight loss; stopping often leads to weight regain (average 2/3 of lost weight over 1-2 years). Some people successfully transition to lifestyle-only maintenance.
Dosing Information
Recommended Dose
Semaglutide (Wegovy): Start 0.25mg weekly, increase every 4 weeks to maintenance dose of 2.4mg weekly. Tirzepatide (Zepbound): Start 2.5mg weekly, increase every 4 weeks to maintenance dose of 10-15mg weekly.
- •Once weekly on the same day each week
- •Can be taken with or without food
- •Titration schedule reduces side effects
- •Some people need to stay at lower doses due to tolerability
Practical Details
Timing
Once weekly injection, same day each week. Many people find fewer GI side effects if injected in the evening.
Duration
Typically long-term or indefinite. Weight regain is common after discontinuation. Some people eventually transition to lifestyle-only maintenance.
Cost
$500-1,500/month without insurance
Insurance coverage varies. Manufacturer savings programs and compounding pharmacies (for semaglutide) may reduce costs. Price should decrease as generics become available.
Risks & Considerations
Potential Risks
- •Common GI side effects: nausea (40-50%), vomiting (20-30%), constipation (20-30%), diarrhea (20-30%)
- •Muscle loss if protein intake is inadequate
- •Gallbladder disease risk is increased
- •Rare but serious: pancreatitis risk (stop medication if severe abdominal pain)
- •Weight regain common if medication is discontinued
- •Long-term effects beyond 2-3 years are still being studied
Possible Side Effects
- •Nausea (usually decreases over time)
- •Constipation or diarrhea
- •Decreased appetite (intended effect)
- •Fatigue initially
- •Injection site reactions
- •Rare: gallstones, pancreatitis
Who Should Avoid This
- •Personal or family history of medullary thyroid carcinoma (MTC)
- •Multiple endocrine neoplasia syndrome type 2 (MEN 2)
- •Pregnancy or breastfeeding
- •History of severe pancreatitis
- •Severe gastrointestinal disease
Key Research
STEP 1: Semaglutide for weight loss
New England Journal of Medicine, 2021
Semaglutide 2.4mg weekly produced 14.9% weight loss vs 2.4% with placebo at 68 weeks. 86% of participants lost ≥5% body weight.
View StudySURMOUNT-1: Tirzepatide for obesity
New England Journal of Medicine, 2022
Tirzepatide produced up to 22.5% weight loss at highest dose (15mg) vs 2.4% with placebo. Over 60% of participants lost ≥20% body weight at highest dose.
View StudyWeight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension
Diabetes, Obesity and Metabolism, 2022
After stopping semaglutide 2.4mg, participants regained 11.6 percentage points of the 17.3% weight lost (about 2/3) over 1 year with similar changes in cardiometabolic variables.
View StudyFrequently Asked Questions
What's the difference between Ozempic and Wegovy?
They're both semaglutide, the same active ingredient. Ozempic is FDA-approved for type 2 diabetes (max dose 2.0mg), while Wegovy is FDA-approved for obesity (max dose 2.4mg). Ozempic is sometimes prescribed off-label for weight loss, though insurance coverage may differ.
Will I regain weight if I stop the medication?
Most people regain significant weight after stopping, studies show about 2/3 of lost weight returns within 1-2 years. This is why many obesity medicine specialists view these as long-term or indefinite treatments. Establishing strong lifestyle habits while on the medication may help some people maintain more weight loss if they stop.
How do I manage the nausea?
Nausea is most common during dose increases and usually improves over time. Strategies: eat smaller meals, avoid high-fat foods, don't eat to the point of fullness (you'll feel fuller than usual), stay hydrated, and consider ginger or peppermint for mild nausea. Your doctor may slow the dose titration if nausea is severe.
Is muscle loss a real concern?
Yes, rapid weight loss from any method typically includes 20-30% lean mass. Strategies to minimize: prioritize protein (0.8-1g per pound of goal body weight minimum), resistance train 2-3x/week, and don't restrict calories too aggressively. Some muscle loss is inevitable, but these strategies significantly reduce it.
Are compounded semaglutide products safe?
Compounded versions are made by compounding pharmacies and are not FDA-approved. Quality varies significantly. The FDA has warned about counterfeit and substandard compounded products. If cost is prohibitive, work with a reputable compounding pharmacy through a licensed provider rather than buying from unverified online sources.
Sources
- STEP 1 Trial (NEJM)(study)
- SURMOUNT-1 Trial (NEJM)(study)
- FDA Approval Information for Wegovy(guideline)
Related Interventions
Disclaimer: This information is for educational purposes only and is not medical advice. Always consult with a qualified healthcare provider before starting any new health practice or supplement. Evidence levels and recommendations can change, this content was last updated December 2025.